BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38583012)

  • 1. Dishevelled Segment Polarity Protein 3 (DVL3) Induced by Bacterial LPS Promotes the Proliferation and Migration of Prostate Cancer Cells through the TLR4 Pathway.
    Zhang Y; Lin N; Liu X; Yao T
    Arch Esp Urol; 2024 Mar; 77(2):193-201. PubMed ID: 38583012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
    Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
    Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 induced Wnt3a-Dvl3 restrains the intensity of inflammation and protects against endotoxin-driven organ failure through GSK3β/β-catenin signaling.
    Yang D; Li S; Duan X; Ren J; Liang S; Yakoumatos L; Kang Y; Uriarte SM; Shang J; Li W; Wang H
    Mol Immunol; 2020 Feb; 118():153-164. PubMed ID: 31884387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
    Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
    J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA testis-specific transcript, Y-linked 15 (TTTY15) promotes proliferation, migration and invasion of colorectal cancer cells via regulating miR-29a-3p/DVL3 axis.
    Zheng XY; Cao MZ; Ba Y; Li YF; Ye JL
    Cancer Biomark; 2021; 31(1):1-11. PubMed ID: 33016900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway.
    Li N; Xu H; Ou Y; Feng Z; Zhang Q; Zhu Q; Cai Z
    Diagn Pathol; 2019 Jan; 14(1):3. PubMed ID: 30636642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase 7-knockdown inhibits oral squamous cell carcinoma cell viability, proliferation, migration and invasion via downregulating dishevelled segment polarity protein 3 expression.
    Jin X; Huang T; Ma C; Duan J; Li R; Zhang W; Tian W
    Exp Ther Med; 2021 Dec; 22(6):1372. PubMed ID: 34659518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells.
    Jain S; Suklabaidya S; Das B; Raghav SK; Batra SK; Senapati S
    Prostate; 2015 Jul; 75(10):1020-33. PubMed ID: 25833062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
    Kim PJ; Park JY; Kim HG; Cho YM; Go H
    BJU Int; 2017 Sep; 120(3):343-350. PubMed ID: 28107606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing DVL3 defeats MTX resistance and attenuates stemness via Notch Signaling Pathway in colorectal cancer.
    Zhao Q; Zhuang K; Han K; Tang H; Wang Y; Si W; Yang Z
    Pathol Res Pract; 2020 Aug; 216(8):152964. PubMed ID: 32414668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation.
    Wang W; Wang J
    Med Sci Monit; 2018 Aug; 24():5588-5597. PubMed ID: 30098292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation.
    Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N
    Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
    Wang L; Zhu R; Huang Z; Li H; Zhu H
    Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
    Zou YF; Xie CW; Yang SX; Xiong JP
    Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide.
    Pei Z; Lin D; Song X; Li H; Yao H
    Cell Immunol; 2008; 254(1):20-7. PubMed ID: 18649875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DUXAP10 promotes the proliferation, migration, and inhibits apoptosis of prostate cancer cells.
    Wang XF; Chen J; Gong YB; Qin YC; Wang L; Li NC
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3699-3708. PubMed ID: 31114994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.